Cargando…
Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia
Blood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia. Our data c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841992/ https://www.ncbi.nlm.nih.gov/pubmed/35198697 http://dx.doi.org/10.1016/j.dib.2022.107926 |
_version_ | 1784650961314119680 |
---|---|
author | Lampret, Barbka Repic Tansek, Mojca Zerjav Groselj, Blaz Sikonja, Jaka Battelino, Tadej Groselj, Urh |
author_facet | Lampret, Barbka Repic Tansek, Mojca Zerjav Groselj, Blaz Sikonja, Jaka Battelino, Tadej Groselj, Urh |
author_sort | Lampret, Barbka Repic |
collection | PubMed |
description | Blood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia. Our data complements the results from the original research article by Tansek et al., 2012 [1]. We performed a BH(4)-loading test in 32 patients after four days of increased protein intake (2000 mg/kg body weight). Blood sampling was performed 96, 72, 48, 24, 16 h, and moments before oral administration of BH(4) in a dose of 20 mg/kg body weight. Additional blood samples were collected 8 and 24 h after its administration. Phenylalanine (Phe) and Tyrosine (Tyr) levels were determined from dried blood spots by tandem mass spectrometry. Phe/Tyr-ratio reached a plateau after three days of increased dietary protein intake. Fifteen patients (47%) responded to BH(4), defined as a decrease of Phe-of at least 30% after 24 h of BH(4) administration. Phe/Tyr-ratios were significantly higher in non-responders compared to responders. In the responder group, Phe/Tyr-ratios decreased in average of 67% (p = 0.001) and 45% (p = 0.001) after 8 and 24 h of BH(4) administration, respectively. Phe/Tyr-ratio decreased after 8 h of drug administration also in the non-responder group, but not 24 h after administration. |
format | Online Article Text |
id | pubmed-8841992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88419922022-02-22 Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia Lampret, Barbka Repic Tansek, Mojca Zerjav Groselj, Blaz Sikonja, Jaka Battelino, Tadej Groselj, Urh Data Brief Data Article Blood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia. Our data complements the results from the original research article by Tansek et al., 2012 [1]. We performed a BH(4)-loading test in 32 patients after four days of increased protein intake (2000 mg/kg body weight). Blood sampling was performed 96, 72, 48, 24, 16 h, and moments before oral administration of BH(4) in a dose of 20 mg/kg body weight. Additional blood samples were collected 8 and 24 h after its administration. Phenylalanine (Phe) and Tyrosine (Tyr) levels were determined from dried blood spots by tandem mass spectrometry. Phe/Tyr-ratio reached a plateau after three days of increased dietary protein intake. Fifteen patients (47%) responded to BH(4), defined as a decrease of Phe-of at least 30% after 24 h of BH(4) administration. Phe/Tyr-ratios were significantly higher in non-responders compared to responders. In the responder group, Phe/Tyr-ratios decreased in average of 67% (p = 0.001) and 45% (p = 0.001) after 8 and 24 h of BH(4) administration, respectively. Phe/Tyr-ratio decreased after 8 h of drug administration also in the non-responder group, but not 24 h after administration. Elsevier 2022-02-04 /pmc/articles/PMC8841992/ /pubmed/35198697 http://dx.doi.org/10.1016/j.dib.2022.107926 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Data Article Lampret, Barbka Repic Tansek, Mojca Zerjav Groselj, Blaz Sikonja, Jaka Battelino, Tadej Groselj, Urh Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia |
title | Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia |
title_full | Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia |
title_fullStr | Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia |
title_full_unstemmed | Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia |
title_short | Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia |
title_sort | data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (bh(4))-responsiveness in patients with hyperphenylalaninemia |
topic | Data Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841992/ https://www.ncbi.nlm.nih.gov/pubmed/35198697 http://dx.doi.org/10.1016/j.dib.2022.107926 |
work_keys_str_mv | AT lampretbarbkarepic dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia AT tansekmojcazerjav dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia AT groseljblaz dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia AT sikonjajaka dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia AT battelinotadej dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia AT groseljurh dataonphenylalaninetotyrosineratiosinassessmentoftetrahydrobiopterinbh4responsivenessinpatientswithhyperphenylalaninemia |